IRIDEX Corp
NASDAQ:IRIX
IRIDEX Corp
Accounts Payable
IRIDEX Corp
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
IRIDEX Corp
NASDAQ:IRIX
|
Accounts Payable
$7.7m
|
CAGR 3-Years
66%
|
CAGR 5-Years
26%
|
CAGR 10-Years
16%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Accounts Payable
$5.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
11%
|
|
Boston Scientific Corp
NYSE:BSX
|
Accounts Payable
$921m
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
Stryker Corp
NYSE:SYK
|
Accounts Payable
$1.2B
|
CAGR 3-Years
18%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
Abbott Laboratories
NYSE:ABT
|
Accounts Payable
$4.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Accounts Payable
$194.4m
|
CAGR 3-Years
24%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
See Also
What is IRIDEX Corp's Accounts Payable?
Accounts Payable
7.7m
USD
Based on the financial report for Mar 30, 2024, IRIDEX Corp's Accounts Payable amounts to 7.7m USD.
What is IRIDEX Corp's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
16%
Over the last year, the Accounts Payable growth was 116%. The average annual Accounts Payable growth rates for IRIDEX Corp have been 66% over the past three years , 26% over the past five years , and 16% over the past ten years .